Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
| Title: | Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial |
|---|---|
| Authors: | Louis E; Resche-Rigon M; Laharie D; Satsangi J; Ding N; Siegmund B; D'Haens G; Picon L; Bossuyt P; Vuitton L; Irving P; Viennot S; Lamb CA; Pollok R; Baert F; Nachury M; Fumery M; Gilletta C; Almer S; Ben-Horin S; Bouhnik Y; Colombel J-F; Hertervig E; GETAID and the SPARE-Biocycle research group |
| Source: | The Lancet Gastroenterology and Hepatology, March 2023 |
| Publisher Information: | Elsevier Ltd |
| Publication Year: | 2023 |
| Collection: | Newcastle University Library ePrints Service |
| Document Type: | article in journal/newspaper |
| Language: | unknown |
| Relation: | https://eprints.ncl.ac.uk/289653 |
| Availability: | https://eprints.ncl.ac.uk/289653 |
| Rights: | https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: | edsbas.F4F13363 |
| Database: | BASE |